Uric Acid and Coronary Artery Disease, Two Sides of a Single Coin: A Determinant of Antioxidant System or a Factor in Metabolic Syndrome

Introduction: Uric acid has antioxidant activity and it is expected to protect against coronary artery disease (CAD). Contradictory, it is a component of metabolic syndrome and so a risk factor for CAD. The associations of plasma total antioxidant capacity (TAOC) and uric acid (UA) as well as ot...

Full description

Bibliographic Details
Main Authors: Babak Bagheri, Mehryar Zargari, Fatemeh Meshkini, Kolsoum Dinarvand, Vahid Mokhberi, Soheil Azizi, Mehdi Rasouli
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2016-02-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/7281/16335_CE(Ra1)_F(GH)_PF1(BMAK)_PFA(AK)_PF2(AGAK).pdf
_version_ 1819145972444299264
author Babak Bagheri
Mehryar Zargari
Fatemeh Meshkini
Kolsoum Dinarvand
Vahid Mokhberi
Soheil Azizi
Mehdi Rasouli
author_facet Babak Bagheri
Mehryar Zargari
Fatemeh Meshkini
Kolsoum Dinarvand
Vahid Mokhberi
Soheil Azizi
Mehdi Rasouli
author_sort Babak Bagheri
collection DOAJ
description Introduction: Uric acid has antioxidant activity and it is expected to protect against coronary artery disease (CAD). Contradictory, it is a component of metabolic syndrome and so a risk factor for CAD. The associations of plasma total antioxidant capacity (TAOC) and uric acid (UA) as well as other risk factors were investigated relative to the occurrence and severity of CAD. Materials and Methods: The study population consisted of 148 males and 152 females aged 35-76 years who were classified as CAD cases and controls according to the results of coronary angiography. The severity of CAD was scored on the basis of the number and the extent of lesions at coronary arteries. The concentrations of UA and TAOC were measured by using of FRAP and enzymatic uricase methods. Results: The prevalence of hypertension, cigarette smoking and diabetes mellitus was more frequent in CAD cases than controls. Patients with CAD when compared with the controls had increased levels of glucose, triglycerides, creatinine, UA, TAOC and decreased levels of HDL- cholesterol. Serum UA was high positive correlate of serum total and LDL-cholesterol, triglyceride, creatinine, BUN, bilirubin, TAOC and negative correlate of glucose and HDL-C. TAOC and its major determinant UA but not bilirubin and albumin are significantly associated with the prevalence and severity of CAD. In multivariate analysis and in the absence of hypertension, UA but not TAOC would remain and be associated with CAD by the OR of 1.57 (1.07- 2.29), p=0.02. If the results adjusted for all major risk factors including hypertension, neither TAOC nor UA would remain in the regression equation. Conclusion: The results suggest that TAOC and UA but not bilirubin and albumin are associated with CAD significantly. But, the correlation is not independent and is attributed to the metabolic syndrome. The measurement of UA and TAOC will not improve the prognostic power beyond the classical risk factors.
first_indexed 2024-12-22T13:06:31Z
format Article
id doaj.art-10cf717dd3404a1786565d7336150f40
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-12-22T13:06:31Z
publishDate 2016-02-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-10cf717dd3404a1786565d7336150f402022-12-21T18:24:52ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2016-02-01102OC27OC3110.7860/JCDR/2016/16335.7281Uric Acid and Coronary Artery Disease, Two Sides of a Single Coin: A Determinant of Antioxidant System or a Factor in Metabolic SyndromeBabak Bagheri0Mehryar Zargari1Fatemeh Meshkini2Kolsoum Dinarvand3Vahid Mokhberi4Soheil Azizi5Mehdi Rasouli6Faculty of Medicine, Departments of Cardiology, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran.Faculty of Medicine, Department of Clinical Biochemistry, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran.Faculty of Medicine, Department of Clinical Biochemistry, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran.Faculty of Medicine, Department of Clinical Biochemistry, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran.Faculty of Medicine, Departments of Cardiology, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran.Faculty of Medicine, Department of Pathology, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran.Faculty of Medicine, Department of Clinical Biochemistry, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran.Introduction: Uric acid has antioxidant activity and it is expected to protect against coronary artery disease (CAD). Contradictory, it is a component of metabolic syndrome and so a risk factor for CAD. The associations of plasma total antioxidant capacity (TAOC) and uric acid (UA) as well as other risk factors were investigated relative to the occurrence and severity of CAD. Materials and Methods: The study population consisted of 148 males and 152 females aged 35-76 years who were classified as CAD cases and controls according to the results of coronary angiography. The severity of CAD was scored on the basis of the number and the extent of lesions at coronary arteries. The concentrations of UA and TAOC were measured by using of FRAP and enzymatic uricase methods. Results: The prevalence of hypertension, cigarette smoking and diabetes mellitus was more frequent in CAD cases than controls. Patients with CAD when compared with the controls had increased levels of glucose, triglycerides, creatinine, UA, TAOC and decreased levels of HDL- cholesterol. Serum UA was high positive correlate of serum total and LDL-cholesterol, triglyceride, creatinine, BUN, bilirubin, TAOC and negative correlate of glucose and HDL-C. TAOC and its major determinant UA but not bilirubin and albumin are significantly associated with the prevalence and severity of CAD. In multivariate analysis and in the absence of hypertension, UA but not TAOC would remain and be associated with CAD by the OR of 1.57 (1.07- 2.29), p=0.02. If the results adjusted for all major risk factors including hypertension, neither TAOC nor UA would remain in the regression equation. Conclusion: The results suggest that TAOC and UA but not bilirubin and albumin are associated with CAD significantly. But, the correlation is not independent and is attributed to the metabolic syndrome. The measurement of UA and TAOC will not improve the prognostic power beyond the classical risk factors.https://jcdr.net/articles/PDF/7281/16335_CE(Ra1)_F(GH)_PF1(BMAK)_PFA(AK)_PF2(AGAK).pdfalbuminatherosclerosisbilirubindiabetes mellitusoxidative stress
spellingShingle Babak Bagheri
Mehryar Zargari
Fatemeh Meshkini
Kolsoum Dinarvand
Vahid Mokhberi
Soheil Azizi
Mehdi Rasouli
Uric Acid and Coronary Artery Disease, Two Sides of a Single Coin: A Determinant of Antioxidant System or a Factor in Metabolic Syndrome
Journal of Clinical and Diagnostic Research
albumin
atherosclerosis
bilirubin
diabetes mellitus
oxidative stress
title Uric Acid and Coronary Artery Disease, Two Sides of a Single Coin: A Determinant of Antioxidant System or a Factor in Metabolic Syndrome
title_full Uric Acid and Coronary Artery Disease, Two Sides of a Single Coin: A Determinant of Antioxidant System or a Factor in Metabolic Syndrome
title_fullStr Uric Acid and Coronary Artery Disease, Two Sides of a Single Coin: A Determinant of Antioxidant System or a Factor in Metabolic Syndrome
title_full_unstemmed Uric Acid and Coronary Artery Disease, Two Sides of a Single Coin: A Determinant of Antioxidant System or a Factor in Metabolic Syndrome
title_short Uric Acid and Coronary Artery Disease, Two Sides of a Single Coin: A Determinant of Antioxidant System or a Factor in Metabolic Syndrome
title_sort uric acid and coronary artery disease two sides of a single coin a determinant of antioxidant system or a factor in metabolic syndrome
topic albumin
atherosclerosis
bilirubin
diabetes mellitus
oxidative stress
url https://jcdr.net/articles/PDF/7281/16335_CE(Ra1)_F(GH)_PF1(BMAK)_PFA(AK)_PF2(AGAK).pdf
work_keys_str_mv AT babakbagheri uricacidandcoronaryarterydiseasetwosidesofasinglecoinadeterminantofantioxidantsystemorafactorinmetabolicsyndrome
AT mehryarzargari uricacidandcoronaryarterydiseasetwosidesofasinglecoinadeterminantofantioxidantsystemorafactorinmetabolicsyndrome
AT fatemehmeshkini uricacidandcoronaryarterydiseasetwosidesofasinglecoinadeterminantofantioxidantsystemorafactorinmetabolicsyndrome
AT kolsoumdinarvand uricacidandcoronaryarterydiseasetwosidesofasinglecoinadeterminantofantioxidantsystemorafactorinmetabolicsyndrome
AT vahidmokhberi uricacidandcoronaryarterydiseasetwosidesofasinglecoinadeterminantofantioxidantsystemorafactorinmetabolicsyndrome
AT soheilazizi uricacidandcoronaryarterydiseasetwosidesofasinglecoinadeterminantofantioxidantsystemorafactorinmetabolicsyndrome
AT mehdirasouli uricacidandcoronaryarterydiseasetwosidesofasinglecoinadeterminantofantioxidantsystemorafactorinmetabolicsyndrome